Nobleoak Life Ltd (ASX: NOL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Nobleoak Life Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Nobleoak Life Ltd (ASX: NOL)
Latest News
Share Market News
Down 30% so far in 2022, leading fund manager Firetrail sees a bright future for this under-the-radar ASX small-cap share
NOL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Nobleoak Life Ltd
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and StrategicPartner (Advised) channels. The company's segment includes Direct business; Strategic Partnerships and Genus. It generates maximum revenue from the Direct segment.
NOL Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
13 Dec 2024 | $1.58 | $-0.04 | -2.46% | 316,237 | $1.65 | $1.65 | $1.58 |
12 Dec 2024 | $1.63 | $-0.01 | -0.61% | 1,381 | $1.61 | $1.63 | $1.61 |
11 Dec 2024 | $1.64 | $0.01 | 0.62% | 884 | $1.60 | $1.64 | $1.60 |
10 Dec 2024 | $1.62 | $0.05 | 3.17% | 100,330 | $1.62 | $1.62 | $1.62 |
09 Dec 2024 | $1.58 | $-0.03 | -1.87% | 265 | $1.58 | $1.58 | $1.58 |
06 Dec 2024 | $1.61 | $0.03 | 1.91% | 19,080 | $1.64 | $1.65 | $1.61 |
05 Dec 2024 | $1.57 | $-0.08 | -4.85% | 5,980 | $1.65 | $1.65 | $1.57 |
04 Dec 2024 | $1.65 | $-0.02 | -1.20% | 230 | $1.65 | $1.65 | $1.65 |
03 Dec 2024 | $1.67 | $0.02 | 1.21% | 11,602 | $1.63 | $1.67 | $1.58 |
02 Dec 2024 | $1.65 | $0.00 | 0.00% | 1,414 | $1.66 | $1.66 | $1.65 |
29 Nov 2024 | $1.65 | $0.00 | 0.00% | 2,218 | $1.65 | $1.67 | $1.65 |
28 Nov 2024 | $1.65 | $0.02 | 1.23% | 32,956 | $1.63 | $1.69 | $1.63 |
27 Nov 2024 | $1.63 | $0.03 | 1.88% | 3,229 | $1.62 | $1.63 | $1.62 |
26 Nov 2024 | $1.60 | $-0.08 | -4.78% | 14,796 | $1.68 | $1.68 | $1.60 |
25 Nov 2024 | $1.68 | $0.02 | 1.20% | 24,297 | $1.66 | $1.68 | $1.66 |
22 Nov 2024 | $1.66 | $0.06 | 3.75% | 22,061 | $1.62 | $1.66 | $1.59 |
21 Nov 2024 | $1.60 | $-0.02 | -1.23% | 675 | $1.60 | $1.60 | $1.60 |
20 Nov 2024 | $1.62 | $-0.03 | -1.82% | 209,872 | $1.62 | $1.66 | $1.62 |
19 Nov 2024 | $1.65 | $0.05 | 3.13% | 65,533 | $1.60 | $1.66 | $1.60 |
18 Nov 2024 | $1.60 | $-0.01 | -0.62% | 20,629 | $1.62 | $1.62 | $1.59 |
15 Nov 2024 | $1.62 | $0.01 | 0.63% | 6,596 | $1.60 | $1.62 | $1.60 |
14 Nov 2024 | $1.60 | $0.02 | 1.27% | 855,346 | $1.58 | $1.60 | $1.58 |
13 Nov 2024 | $1.58 | $0.02 | 1.28% | 17,675 | $1.58 | $1.58 | $1.56 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
28 Nov 2024 | Anthony Brown | Issued | 66,464 | $109,000 |
Conversion of securities. Estimated at an average
|
28 Nov 2024 | Anthony Brown | Expiry | 165,331 | $271,969 |
As advised by the company. 541,159 Rights, lapsed
|
28 Nov 2024 | Anthony Brown | Exercise | 66,464 | $109,000 |
Conversion of securities. Estimated at an average, 706,490 Rights
|
01 Nov 2024 | Anthony Brown | Buy | 2,174 | $3,261 |
On-market trade.
|
18 Oct 2024 | Anthony Brown | Buy | 7,826 | $12,325 |
On-market trade.
|
14 Dec 2023 | Anthony Brown | Issued | 287,703 | $495,999 |
Issue of securities. Estimated, VWAP, 772,954 Rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Stephen James Harrison | Non-Executive ChairmanNon-Executive Director | Jan 2011 |
Mr Harrison was appointed as a Director of the Company in January 2011 and as Chair of the Company in November 2018. Mr Harrison has over 36 years of experience in financial services, funds management, private equity and accounting. He previously held Director positions with Investec Funds Management and the Australian subsidiary of US based fund manager Sanford C Bernstein. He is Member of the Risk Committee and a member of the Product & insurance committee.
|
Mr Andrew Crawfurd Gale | Non-Executive Director | Sep 2024 |
Mr Gale has over 40 years experience in financial services. His former executive roles include Executive Director with Chase Corporate Advisory, CEO and Managing Director for Count Financial Ltd, Managing Partner for Deloitte Actuaries & Consultants, and senior executive roles at MLC and AMP. Mr Gale also has 17 years experience as a non-executive director, including as a former Director and Chair of the SMSF Association, and non-executive director of Mortgage Choice Ltd, NULIS Nominees (Australia) Limited (MLC Super Trustee), Harper Bernays Limited, NAB Wealth Advice & Licences Board and MLC Life & Administrator Board (and associated entities including MLC Limited). Mr Gale is the current Chair of Top Blokes Foundation, was the founding Chair and Director of the Australian Society for Progress & Wellbeing, and has had numerous other NFP roles. He has experience chairing board committees.
|
Ms Sarah Jane Brennan | Non-Executive Director | Dec 2021 |
Ms Brennan was appointed as a Director of the Company in December 2021. Ms Brennan has over 26 years' experience in financial services, encompassing life insurance, financial planning, superannuation, private client advisory, broking and banking. Ms Brennan is currently Managing Director of BMFS Consulting. She held previous senior roles with Deutsche Bank including as Principal Officer of Deutsche Life, MLC Limited and Citigroup Life. She was also the Founder and Managing Partner of Comparator Business Benchmarking, a leading provider of benchmarking to Australian financial services markets. She is Chair of the Risk Committee & Member of the Product & Insurance Committee.
|
Ms Inese Indra Kingsmill | Non-Executive Director | Dec 2019 |
Mr Kingsmill was appointed as a Director of the Company in December 2019. Prior to joining the Company, Ms Kingsmill gained senior experience across marketing, digital, e commerce, sales and customer facing functions at a range of companies. Previous positions include Chief Marketing Officer at Virgin Australia, Director of Consumer Marketing and Director of Corporate Marketing at Telstra, and Director Partner Strategy at Microsoft. She was formerly a Non-Executive Director of WorkVentures, Rhipe Limited, Spirit Technology Solutions and Chair of the Australian Association of National Advertisers. He is Member of the Product & Insurance Committee & Member of the Finance & Investment and the Risk Committee as well.
|
Mr Kevin Hamman | Non-Executive DirectorNon-Executive Deputy Chairman | Jan 2011 |
Mr Hamman was appointed as a Director of the Company in January 2011 and Deputy Chair of the Board of Directors effective 2 December 2021. Mr Hamman has over 36 years of experience in the financial services industry and has held various senior management and Director roles in investment and private banking. Mr Hamman currently holds and previously held several executive directorships and senior management positions in private and public companies in the financial services, property development and investment industries including within the Private Client Division of Investec Bank Ltd, Cape of Good Hope Bank Ltd, First National Bank Ltd and Barclays Bank Ltd. He is member of the Risk Committee & Chair of the Finance & Investment Committee.
|
Mr Andrew James Boldeman | Non-Executive Director | Jun 2020 |
Mr Boldeman was appointed as a Director of the Company in June 2020. Mr Boldeman has spent his career in the life insurance and broader financial services industries in Australia, Asia and the UK. From 2013 to 2020, Mr Boldeman was the Managing Director of Avant Mutual, Australia's largest doctor's organization which includes Avant Insurance, Avant Law, Doctors Health Fund as well as several technology and financial services businesses. From 2007 to 2013, Mr Boldeman was CEO Group Life at TAL. Mr Boldeman has also previously spent time as an Appointed Actuary and as a management consultant. He is Chair of the Product & Insurance Committee & & Member of the Finance & Investment Committee.
|
Mr Anthony Ross Brown | Chief Executive OfficerExecutive Director | Jul 2013 |
Mr Brown was appointed Chief Executive Officer of the Company in July 2012, and a Director of the Company in July 2013. Mr Brown has 31 years of experience in general management, finance, strategy, operations, marketing and distribution. Mr Brown was previously Chief Operating Officer at AMP Capital, Head of Commercial Insurance Marketing at Promina/Suncorp, Publisher at CCH Australia and Manager at KPMG. He is Member of the Product & Insurance Committee & Member of the Finance & Investment Committee.
|
Ms Suzanne Barron | Joint Company Secretary | Jun 2022 |
-
|
Scott Pearson | Chief Financial Officer |
-
|
|
Matthew Wilson | Chief Risk Officer |
-
|
|
Suzanne Barron | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
J P Morgan Nominees Australia Pty Limited | 20,599,461 | 23.85% |
BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 8,554,143 | 9.90% |
Citicorp Nominees Pty Limited | 6,692,211 | 7.75% |
UBS Nominees Pty Ltd | 6,156,480 | 7.13% |
Anthony R Brown Brohok | 5,855,769 | 6.78% |
Es Gordon Family Trust And Super Fund Evanic Investments | 5,415,718 | 6.27% |
Scott Gant Quay Super Fund - Moneris | 4,388,886 | 5.08% |
Netwealth Investments Limited <Wrap Services A/C> | 3,619,099 | 4.19% |
Ff Okram Pty Ltd <The Ff Okram A/C> | 3,102,439 | 3.59% |
Neweconomy Com Au Nominees Pty Limited <900 Account> | 2,587,416 | 3.00% |
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 2,503,021 | 2.90% |
Innovation Holdings Australia Pty Ltd | 1,641,025 | 1.90% |
Kevin Hamman Future Super Tk Consulting Kh Developments | 1,078,619 | 1.25% |
Greenwich Capital Partners Advisory | 986,508 | 1.14% |
Stephen Harrison Julie Mcconaghy Jasmah Msj Capital | 972,700 | 1.13% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 720,721 | 0.83% |
Gwlh Pty Ltd <Gwlh Super Fund A/C> | 647,447 | 0.75% |
National Nominees Limited | 570,825 | 0.66% |
HSBC Custody Nominees (Australia) Limited Gsi Eda | 566,575 | 0.66% |
Ruthvic Pty Ltd <Ruthvic Super Fund A/C> | 409,438 | 0.47% |